Quantitative RT-PCR comparison of the urea and nitric oxide cycle gene transcripts in adult human tissues

Molecular Genetics and Metabolism

Volumn 97, Issue 2, 2009, Pages 121-127

  Neill, Meaghan Anne ^a   Aschner, Judy ^b   Barr, Frederick ^a,b   Summar, Marshall L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arginine; Citrulline; Expression; Liver; Nitric oxide; qRT PCR; RNA; Urea cycle

Indexed keywords

ARGININE; CITRULLINE; NITRIC OXIDE; NITROGEN; ORNITHINE; UREA;

AMINO ACID SYNTHESIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; METABOLISM; NITRIC OXIDE CYCLE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE METABOLISM; UREA CYCLE;

ADULT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NITRIC OXIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UREA;

EID: 67349285169     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.02.009     Document Type: Article

References (35)

1. Krebs H.A., and Henseleit K. Untersuchungen uber die harnstoffbildung im tierkorper. Hoppe-Seyler's Z. Physiol. Chem. 210 (1932) 325-332
2. Morris Jr. S.M. Regulation of enzymes of urea and arginine synthesis. Annu. Rev. Nutr. 12 (1992) 81-101
3. Schofield J.P. Molecular studies on an ancient gene encoding for carbamoyl-phosphate synthetase. Clin. Sci. 84 (1993) 119-128
4. Jackson M.J., Beaudet A.L., and O'Brien W.E. Mammalian urea cycle enzymes. Annu. Rev. Genet. 20 (1986) 431-464
5. Cederbaum S.D., et al. Arginases I and II: do their functions overlap?. Mol. Genet. Metab. 81 Suppl. 1 (2004) S38-S44
6. Mount P.F., and Power D.A. Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol. (Oxf) 187 (2006) 433-446
7. Massion P.B., Pelat M., Belge C., and Balligand J.L. Regulation of the mammalian heart function by nitric oxide. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 142 (2005) 144-150
8. Sullivan J.C., and Pollock J.S. NOS 3 subcellular localization in the regulation of nitric oxide production. Acta Physiol. Scand. 179 (2003) 115-122
9. Canter J.A., et al. Genetic variation in the mitochondrial enzyme carbamyl-phosphate synthetase I predisposes children to increased pulmonary artery pressure following surgical repair of congenital heart defects: a validated genetic association study. Mitochondrion 7 (2007) 204-210
10. Barr F.E., et al. J. Thorac. Cardiovasc. Surg. 134 (2007) 319-326
11. Kallianpur A.R., et al. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 35 (2005) 1155-1164
12. Summar M.L., et al. Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Mol. Genet. Metab. 81 Suppl. (2004) 12-19
13. Summar M.L., et al. Hypertension 43 (2004) 186-191
14. Barr F.E., et al. Effect of cardiopulmonary bypass on urea cycle intermediates and nitric oxide levels after congenital heart surgery. J. Pediatr. 142 (2003) 26-30
15. Pearson D.L., et al. Neonatal pulmonary hypertension - urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N. Engl. J. Med. 344 (2001) 1832-1838
16. Wang Y., Newton D.C., and Marsden P.A. Neuronal NOS: gene structure, mRNA diversity, and functional relevance. Crit. Rev. Neurobiol. 13 (1999) 21-43
17. Tuchman M., Mauer S.M., Holzknecht R.A., Summar M.L., and Vnencak-Jones C.L. Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonaemia in two sisters with carbamyl phosphate synthetase deficiency. J. Inherit. Metab. Dis. 15 (1992) 269-277
18. Tuchman M. Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency [letter]. N. Engl. J. Med. 320 (1989) 1498-1499
19. Windmueller H.G., and Spaeth A.E. Source and fate of circulating citrulline. Am. J. Physiol. 241 (1981) E473-E480
20. Yu H., et al. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J. Histochem. Cytochem. 51 (2003) 1151-1160
21. Kepka-Lenhart D., Ash D.E., and Morris S.M. Determination of mammalian arginase activity. Methods Enzymol. 440 (2008) 221-230
22. Nelin L.D., et al. Am. J. Physiol. Cell Physiol. 293 (2007) C632-C640
23. Ricciardolo F.L. cNOS-iNOS paradigm and arginase in asthma. Trends Pharmacol. Sci. 24 (2003) 560-561
24. Meurs .H., Maarsingh H., and Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 24 (2003) 450-455
25. Hallemeesch M.M., Lamers W.H., and Deutz N.E. Reduced arginine availability and nitric oxide production. Clin. Nutr. 21 (2002) 273-279
26. Mori M., and Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun. 275 (2000) 715-719
27. Gropman A.L., Summar M., and Leonard J.V. Neurological implications of urea cycle disorders. J. Inherit. Metab. Dis. 30 6 (2007)
28. Caldovic L., et al. Late onset N-acetylglutamate synthase deficiency caused by hypomorphic alleles. Hum. Mutat. 25 (2005) 293-298
29. Summar M.L., et al. Unmasked adult-onset urea cycle disorders in the critical care setting. Crit. Care Clin. 21 (2005) S1-S8
30. Summar M. Current strategies for the management of neonatal urea cycle disorders. J. Pediatr. 138 (2001) S30-S39
31. Morris C.R., et al. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?. Am. J. Respir. Crit. Care Med. 168 (2003) 63-69
32. Pita A.M., et al. Plasma urea-cycle-related amino acids, ammonium levels, and urinary orotic acid excretion in short-bowel patients managed with an oral diet. Clin. Nutr. 22 (2003) 93-98
33. Butterworth R.F. Effects of hyperammonaemia on brain function. [Review] [75 refs.]. J. Inherit. Metab. Dis. 21 Suppl. 1 (1998) 6-20
34. Smith H.A., et al. J. Thorac. Cardiovasc. Surg. 132 (2006) 58-65
35. Hayashi T., et al. l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc. Natl. Acad. Sci. USA 102 (2005) 13681-13686